Home » International News » 2013 » June » June 3

International News on June 3, 2013

The Gores Group Acquires Etrali, a Subsidiary of France Telecom Orange
The Gores Group, a global investment firm, and France Telecom-Orange, a worldwide telecom operator, announced today that The Gores Group has completed the acquisition of Etrali, Orange Business Services – Trading Solutions, a subsidiary of France Telecom Orange Business Wire India

Toshiba Begins Sample Shipment of Mission Critical 1.6TB Large Capacity Enterprise SSDs
Toshiba Corporation (TOKYO: 6502) today announced that it will start sample shipments of its enterprise SSD (eSSD) "PX02SM" series, including "PX02SMB160", which has a 1.6TB capacity, the largest-class [1] of storage capacity in the market, in July. Business Wire India

Gemalto delivers micro-banking technology in Bangladesh
Regulatory News: Business Wire India

The Need to Save on Capital Costs Spurs Adoption of Data Centre Services in GCC Countries, says Frost & Sullivan
Over the past few years, data centre services in the Gulf Cooperation Council (GCC) countries have risen to the forefront as part of a general trend towards outsourcing and the need to control business costs Business Wire India

Rolman Group to Move into its 33,000 sqm State-of-the-art Headquarters Facility in JAFZA in Q3 2013
The Rolman Group, a Dubai-based company, which is one of the largest and most established distributors of bearings and related technical application-specific services in the Middle East and Africa, has announced its move into its new larger state-of-the-art headquarters in the Jebel Ali Free Zone Authority (JAFZA) in Dubai Business Wire India

Superiority of afatinib* over comparator chemotherapy for patients with EGFR mutation-positive advanced lung cancer is reinforced by second Phase III study
Business Wire India

Takeda Highlights Data from Clinical Trial Examining the Use of ADCETRIS® (Brentuximab Vedotin) in Pediatric Patients
Takeda Pharmaceutical Company Limited (TSE:4502) has announced interim data from a Phase 1/2, open-label, multicenter study with ADCETRIS® (brentuximab vedotin) in pediatric patients diagnosed with CD30-positive relapsed or refractory Hodgkin lymphoma (HL) or relapsed or refractory systemic anaplastic large cell lymphoma (sALCL) Business Wire India

Comment on this story